Answers are grounded in this paper and cite their sources.
The FSHD-HI provides researchers and clinicians with a reliable and valid mechanism to measure multifaceted disease burden in patients with FSHD. The FSHD-HI may facilitate quantification of therapeutic effectiveness, as demonstrated by its use as a secondary and exploratory measure in several clinical trials.
No takes yet. Share an insight, caveat, or question.
Varma et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: